Story
BEL 20 Falls to One-Month Low on Tech and Healthcare Weakness
Summary
Belgium's benchmark BEL 20 index closed down 0.95% on Friday, hitting a new one-month low as significant losses in technology and healthcare stocks offset gains elsewhere in the market.
Belgium's benchmark stock index, the BEL 20, fell 0.95% to a new one-month low at the close of trading on Friday, pulled down by significant declines in the technology and healthcare sectors.
Sector Performance
The session's downturn was primarily driven by weakness among key index constituents in technology and healthcare. According to data from the Brussels Stock Exchange, the market's worst performers were concentrated in these industries.
- Melexis NV (EBR:MLXS), a semiconductor company, led the decliners, falling 7.13%.
- Healthcare firms also faced heavy selling pressure, with UCB SA (EBR:UCB) dropping 5.16% and Argen-X (EBR:ARGX) losing 4.14%.
Market Breadth and Gainers
AdDespite the index's negative performance, market breadth on the Brussels Stock Exchange was nearly balanced, with 47 stocks rising and 46 declining, while 14 remained unchanged. This indicates that the losses were concentrated in heavily weighted index members rather than being market-wide.
A few companies posted strong gains, bucking the overall trend. Stainless steel producer Aperam SA (AS:APAM) was the top performer on the BEL 20, climbing 4.31%. It was followed by Azelis Corporate Services NV (EBR:AZE), which added 3.43%, and D’Ieteren NV (EBR:IETB), up 1.23%.
Broader Market Context
In the wider commodities market, prices for key assets were also lower. Crude oil for August delivery fell 1.12% to $71.27 a barrel, while the September Brent contract declined 0.73% to $75.74 a barrel. Gold Futures for August delivery were also down, trading 0.49% lower at $4,120.37 a troy ounce. In currency markets, the EUR/USD and EUR/GBP pairs were largely unchanged.